Literature DB >> 22362896

Naturally occurring regulatory T cells: markers, mechanisms, and manipulation.

Klaus G Schmetterer1, Alina Neunkirchner, Winfried F Pickl.   

Abstract

Naturally occurring CD4(+)CD25(high) forkhead box protein 3 (FOXP3)(+) regulatory T cells (nTregs) are key mediators of immunity, which orchestrate and maintain tolerance to self and foreign antigens. In the recent 1.5 decades, a multitude of studies have aimed to define the phenotype and function of nTregs and to assess their therapeutic potential for modulating immune mediated disorders such as autoimmunity, allergy, and episodes of transplant rejection. In this review, we summarize the current knowledge on the biology of nTregs. We address the exact definition of nTregs by specific markers and combinations thereof, which is a prerequisite for the state-of-the-art isolation of defined nTreg populations. Furthermore, we discuss the mechanism by which nTregs mediate immunosuppression and how this knowledge might translate into novel therapeutic modalities. With first clinical studies of nTreg-based therapies being finished, questions concerning the reliable sources of nTregs are becoming more and more eminent. Consequently, approaches allowing conversion of CD4(+) T cells into nTregs by coculture with antigen-presenting cells, cytokines, and/or pharmacological agents are discussed. In addition, genetic engineering approaches for the generation of antigen-specific nTregs are described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362896     DOI: 10.1096/fj.11-193672

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Subconjunctival injection of in vitro transforming growth factor-β-induced regulatory T cells prolongs allogeneic corneal graft survival in mice.

Authors:  Qing Xu; Xiaobo Tan; Yingnan Zhang; Ying Jie; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival.

Authors:  Mohammad A Khan; Sana Moeez; Suhail Akhtar
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

Review 3.  Cell therapy for immunosuppression after kidney transplantation.

Authors:  Christian Morath; Anita Schmitt; Martin Zeier; Michael Schmitt; Flavius Sandra-Petrescu; Gerhard Opelz; Peter Terness; Matthias Schaier; Christian Kleist
Journal:  Langenbecks Arch Surg       Date:  2015-06-17       Impact factor: 3.445

4.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

Review 5.  Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.

Authors:  Christian Morath; Anita Schmitt; Florian Kälble; Martin Zeier; Michael Schmitt; Flavius Sandra-Petrescu; Gerhard Opelz; Peter Terness; Matthias Schaier; Christian Kleist
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

Review 6.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

7.  Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  David N Abarbanel; Scott M Seki; Yinka Davies; Natalie Marlen; Joseph A Benavides; Kathleen Cox; Kari C Nadeau; Kenneth L Cox
Journal:  J Clin Immunol       Date:  2012-10-09       Impact factor: 8.317

Review 8.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

9.  Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Authors:  Fang Hua; Ning Kang; Yun-An Gao; Lian-Xian Cui; De-Nian Ba; Wei He
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 10.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.